Molecular mechanism of diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0009-8981(00)00240-0PMID 10841915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Familial Factors in Diabetic Nephropathy

  2000cited by this paper
• Biochemical Aspects of Diabetic Nephropathy

  2000cited by this paper
• Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients.

  1998cited by this paper
• Induction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species

  1998cited by this paper
• High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells.

  1998cited by this paper
• Increased Excretion of Urinary Transforming Growth Factor Beta 1 in Patients with Diabetic Nephropathy

  1998cited by this paper
• Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy.

  1998cited by this paper
• Microalbuminuria in Diabetes

  1998cited by this paper
• Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species.

  1998cited by this paper
• Markers of diabetic nephropathy.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

  1998cited by this paper
• Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats

  1997cited by this paper
• Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells

  1997cited by this paper
• Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.

  1997cited by this paper
• Renal excretion of endothelin in children

  1997cited by this paper
• Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells.

  1997cited by this paper
• Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus

  1996cited by this paper
• The Role of Hyperglycemia in the Development of Diabetic Complications

  1996cited by this paper
• Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment.

  1996cited by this paper
• Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.

  1996cited by this paper
• Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus.

  1996cited by this paper
• Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor

  1996cited by this paper
• Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key Mediator

  1995cited by this paper
• The dark side of glucose

  1995cited by this paper
• Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

  1994cited by this paper
• Immunohistochemical localization of collagen VI in diabetic glomeruli.

  1994cited by this paper
• Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

  1994cited by this paper
• mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats

  1993cited by this paper
• Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients

  1993cited by this paper
• Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Immunochemical Detection of Advanced Glycation End Products in Renal Cortex From STZ-Induced Diabetic Rat

  1993cited by this paper
• Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention.

  1992cited by this paper
• Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.

  1992cited by this paper
• The link between hyperglycaemia and diabetic nephropathy

  1992cited by this paper
• The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis.

  1991cited by this paper
• Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium.

  1991cited by this paper
• Differential expression of basement membrane collagen chains in diabetic nephropathy.

  1991cited by this paper
• High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures.

  1991cited by this paper
• Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.

  1991cited by this paper
• The kidney and hypertension in diabetes mellitus

  1989cited by this paper
• Characterization and localization of basement membrane-associated heparan sulfate proteoglycan in human tissues.

  1989cited by this paper
• Cognitive function in long survivors of childhood acute lymphoblastic leukemia.

  1989cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Microalbuminuria as a predictor of clinical diabetic nephropathy.

  1987cited by this paper
• Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors

  1986cited by this paper
• The pathology of diabetic nephropathy

  1986cited by this paper
• The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus

  1985cited by this paper
• Structural-functional relationships in diabetic nephropathy.

  1984cited by this paper
• The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy

  1983cited by this paper

• Hallmarks of Quercetin Benefits as a Functional Supplementary in the Management of Diabetes Mellitus-Related Maladies: From Basic to Clinical Applications.

  2025cites this paper
• High glucose couples DJ-1 with PTEN to activate PDGFRβ for renal proximal tubular cell injury

  2025cites this paper
• Insights into diabetic nephropathy biomarkers with focus on existing indices and potential future developments

  2025cites this paper
• Pharmacological activities of Dencichine: A review of recent progress.

  2025cites this paper
• The emerging role of nanoscaffolds in chronic diabetic wound healing: a new horizon for advanced therapeutics

  2024cites this paper
• Comparison of complete blood count parameters in different severity of proteinuria among patients with type 2 diabetes mellitus

  2024cites this paper
• Neuroprotective effects of kudzu root extract alone and in combination with maqui berry extract in streptozotocin-induced neuropathic pain

  2024cites this paper
• The relation between autophagy modulation by intermittent fasting and aquaporin 2 expression in experimentally induced diabetic nephropathy in albino rat.

  2024cites this paper
• Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions

  2024cites this paper
• Potential utilization of ferulic acid and its derivatives in the management of metabolic diseases and disorders: An insight into mechanisms.

  2024cites this paper
• Molecular Mechanism of Diabetic Nephropathy

  2022cites this paper
• Screening of key genes associated with m6A methylation in diabetic nephropathy patients by CIBERSORT and weighted gene coexpression network analysis.

  2022cites this paper
• Clopidogrel delays and can reverse diabetic nephropathy pathogenesis in type 2 diabetic db/db mice

  2022cites this paper
• Gingerol, a Natural Antioxidant, Attenuates Hyperglycemia and Downstream Complications

  2022cites this paper
• 6-Gingerol, a Bioactive Compound of Ginger Attenuates Renal Damage in Streptozotocin-Induced Diabetic Rats by Regulating the Oxidative Stress and Inflammation

  2021cites this paper
• Melatonin Improves Endoplasmic Reticulum Stress-Mediated IRE1α Pathway in Zücker Diabetic Fatty Rat

  2021cites this paper
• World Journal of Diabetes and

  2021cites this paper
• Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats

  2021influential citation
• Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis.

  2021cites this paper
• Combination therapy with Exendin-4 and islet transplantation as a synergistic treatment for diabetic nephropathy in rats.

  2021cites this paper
• Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-β/Smad and JAK2/STAT3/SOCS1 pathway.

  2021cites this paper
• Betulinic acid reduces the complications of autoimmune diabetes on the body and kidney through effecting on inflammatory cytokines in C57BL/6 mice

  2021cites this paper
• Effect of Cyperus squarrosus plant extracts on diabetic neuropathy in Streptozotocin (STZ)–induced diabetic rats

  2021cites this paper
• Sinomenine improve diabetic nephropathy by inhibiting fibrosis and regulating the JAK2/STAT3/SOCS1 pathway in streptozotocin-induced diabetic rats.

  2020cites this paper
• Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications.

  2020cites this paper
• Discovery of a coumarin derivative as Nrf2 activator mitigating oxidative stress and fibrosis in mesangial cells under high glucose.

  2020cites this paper
• Diabetic Nephropathy: Perspective on Extracellular Vesicles

  2020cites this paper
• Usefulness of urinary fibronectin and laminin as biomarkers of glomerular injury in diabetics in Port Harcourt, Nigeria

  2020cites this paper
• Cathelicidin-BF attenuate kidney injury through inhibiting oxidative stress, inflammation and fibrosis in streptozotocin-induced diabetic rats.

  2020cites this paper
• Dencichine ameliorates renal injury by improving oxidative stress, apoptosis and fibrosis in diabetic rats.

  2020cites this paper
• Evaluation of glutathione S-transferase polymorphism in Iranian patients with type 2 diabetic microangiopathy

  2020cites this paper
• Branched Chain Amino Acids Protects Rat Mesangial Cells from High Glucose by Modulating TGF-β1 and BMP-7

  2019cites this paper
• Evaluation of DNA damage and Environmental Antioxidants defense systems in type 2 diabetes mellitus Patients

  2019cites this paper
• The confounding role of common diabetes medications in developing acute renal failure: A data mining approach with emphasis on drug-drug interactions

  2019cites this paper
• Deacetylation of S6 kinase promotes high glucose–induced glomerular mesangial cell hypertrophy and matrix protein accumulation

  2019cites this paper
• Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix

  2019cites this paper
• The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis

  2019cites this paper
• DMSO_A_221642 2433..2440

  2019cites this paper
• Early markers of heart and kidney damage in Fabry disease

  2018cites this paper
• A study on correlation between oxidative stress parameters and inflammatory markers in type 2 diabetic patients with kidney dysfunction in north Indian population

  2018cites this paper
• Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes.

  2018cites this paper
• Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy

  2017cites this paper
• Alterations in Some Oxidative Stress Markers in Diabetic Nephropathy

  2017cites this paper
• Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications.

  2017cites this paper
• Diabetes Mellitus induces alterations in metallothionein protein expression and metal levels in the testis and liver

  2017cites this paper
• Klotho in diabetes and diabetic nephropathy : a brief update review

  2017cites this paper
• Kidney histology in streptozotocin-induced diabetic male Wistar rats treated with combined extract of temulawak rhizome and belimbing wuluh fruit

  2017cites this paper
• Therapeutic Potential of Chinese Prescription Hachimi-Jio-Gan and Its Crude Drug Corni Fructus against Diabetic Nephropathy

  2017cites this paper
• Hydrophobic motif site-phosphorylated protein kinase CβII between mTORC2 and Akt regulates high glucose-induced mesangial cell hypertrophy.

  2016cites this paper
• Increased sphingosine 1‐phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy

  2016cites this paper
• Association of serum YKL-40 levels with urinary albumin in Egyptian patients with type 1 diabetes mellitus

  2016cites this paper
• Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy

  2016cites this paper
• Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials

  2016cites this paper
• Effect of morroniside on glomerular mesangial cells through AGE–RAGE pathway

  2016cites this paper
• Inhibitory effect of quercetin in the formation of advance glycation end products of human serum albumin: An in vitro and molecular interaction study.

  2015cites this paper
• [Comorbidities as risk factors of chronic kidney disease in HIV-infected persons].

  2015cites this paper
• Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.

  2015cites this paper
• Glycation, carbonyl stress and AGEs inhibitors: a patent review

  2015cites this paper
• Immunohistochemical distribution of leptin in kidney tissues of melatonin treated diabetic rats

  2015cites this paper
• High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression.

  2015cites this paper
• Efficacy of urinary N-acetyl-β-D-glucosaminidase to evaluate early renal tubular damage as a consequence of type 2 diabetes mellitus: a cross-sectional study

  2015cites this paper
• Inhibitory Effects of Methonolic Pericarp Extract of Feronia limonia on in vitro Protein Glycoxidation

  2015cites this paper
• Correlation of Urinary Markers and Urine Creatinine in Glomerulopathy at the Onset of Type-II Diabetic Subjects

  2015cites this paper
• Urinary Markers for Early Detection of Diabetic Nephropathy in Type 1 Diabetes Mellitus

  2015cites this paper
• Flavonoid rich fraction of Punica granatum improves early diabetic nephropathy by ameliorating proteinuria and disturbed glucose homeostasis in experimental animals

  2015cites this paper
• Glutathione s-transferase m1 and t1 gene polymorphisms are not associated with increased risk of gestational diabetes mellitus development.

  2014cites this paper
• Urinary Biomarkers for Early Diabetic Nephropathy in Everyday Practice

  2014cites this paper
• Protective effect of diosmin against diabetic neuropathy in experimental rats.

  2014cites this paper
• Mesenchymal Stem Cell-Based Treatment for Microvascular and Secondary Complications of Diabetes Mellitus

  2014cites this paper
• Pharmacological and Toxicological Studies of Azathioprine Loaded Chitosan Based Nanoparticles

  2014cites this paper
• IN VITRO FREE RADICAL SCAVENGING ACTIVITY OF AQUEOUS FRUIT EXTRACT OF COCCINA INDICA

  2014cites this paper
• Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats.

  2014cites this paper
• High Glucose Forces a Positive Feedback Loop Connecting Akt Kinase and FoxO1 Transcription Factor to Activate mTORC1 Kinase for Mesangial Cell Hypertrophy and Matrix Protein Expression*

  2014cites this paper
• The influence of age and type 2 diabetes on cardioprotective interventions against myocardial ischaemia-reperfusion injury.

  2013cites this paper
• Response surface methodology as optimization strategy for reduction of reactive carbonyl species in foods by means of phenolic chemistry.

  2013cites this paper
• Differential effects of Smad3 targeting in a murine model of chronic kidney disease

  2013cites this paper
• Protective Effects of Adiponectin from Nephropathy and Atherosclerosis in Type 2 Diabetic Rats : Possible Mechanisms

  2013cites this paper
• Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice.

  2013cites this paper
• Lyoniresinol 3α-O-β-D-Glucopyranoside-Mediated Hypoglycaemia and Its Influence on Apoptosis-Regulatory Protein Expression in the Injured Kidneys of Streptozotocin-Induced Mice

  2013cites this paper
• Transforming Growth Factor β Integrates Smad 3 to Mechanistic Target of Rapamycin Complexes to Arrest Deptor Abundance for Glomerular Mesangial Cell Hypertrophy*

  2013cites this paper
• Decrease of FGF Receptor (FGFR) and Interstitial Fibrosis in the Kidney of Streptozotocin-induced Diabetic Rats

  2013cites this paper
• Managing diabetes complications in the clinical arena

  2012cites this paper
• Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI.

  2012cites this paper
• Urinary Markers of Glomerular Injury in Diabetic Nephropathy

  2012cites this paper
• Study of Azathioprine Effects on Serum Markers of Insulin Resistance in Male Rats

  2012cites this paper
• Effect of a Combined Extract of Orostachys japonicus with Medicinal Plants on the Lipid Composition of the Liver and Kidney from Streptozotocin-induced Diabetic Rats

  2012cites this paper
• Tip 1 Diyabet (T1D)'li Türk Hastalarda Glutatyon-S-Transferaz (GSTT1 ve GSTM1) Gen Polimorfizmlerinin Araştırılması

  2012cites this paper
• Thrombophilic disorders: a real threat to patients with end-stage renal disease on hemodialysis and at the time of renal transplantation

  2012cites this paper
• Polyphenol rich fruit pulp of Aegle marmelos (L.) Correa exhibits nutraceutical properties to down regulate diabetic complications — An in vitro study

  2012cites this paper
• Beneficial Effect of Rhein on the Treatment of Diabetic Nephropathy in Nonobese Diabetic (NOD) Mice

  2012cites this paper
• Evaluation of glutathione S-transferase P1 genetic variants affecting type-2 diabetes susceptibility and glycemic control

  2012cites this paper
• Renal Protective Effect of Xiao-Chai-Hu-Tang on Diabetic Nephropathy of Type 1-Diabetic Mice

  2012cites this paper
• Proteinuria: From Molecular to Clinical Applications in Glomerulonephritis

  2012cites this paper
• Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy.

  2011cites this paper
• CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells

  2011cites this paper
• Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.

  2011influential citation
• The effects of the aqueous extract of Pterocarpus santalinus heartwood and vitamin E supplementation in streptozotocin-induced diabetic rats

  2011cites this paper
• Chinese Medicine for Treating Diabetic Nephropathy

  2011cites this paper
• Role of Bone Morphogenetic Proteins-7 (BMP-7) in the Renal Improvement Effect of DangGui (Angelica sinensis) in Type-1 Diabetic Rats

  2011cites this paper
• NAD Blocks High Glucose Induced Mesangial Hypertrophy via Activation of the Sirtuins-AMPK-mTOR Pathway

  2011cites this paper